Calidi Biotherapeutics Stock Price Prediction
| CLDI Stock | 1.24 0.05 3.88% |
Momentum 38
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (1.56) | EPS Estimate Current Year (7.44) | EPS Estimate Next Year (5.52) | Wall Street Target Price 120.0048 | EPS Estimate Current Quarter (1.68) |
Using Calidi Biotherapeutics hype-based prediction, you can estimate the value of Calidi Biotherapeutics from the perspective of Calidi Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Calidi Biotherapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Calidi because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Calidi Biotherapeutics after-hype prediction price | USD 1.23 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Calidi Biotherapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Calidi Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Calidi Biotherapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Calidi Biotherapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Calidi Biotherapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Calidi Biotherapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Calidi Biotherapeutics Estimiated After-Hype Price Volatility
In the context of predicting Calidi Biotherapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Calidi Biotherapeutics' historical news coverage. Calidi Biotherapeutics' after-hype downside and upside margins for the prediction period are 0.06 and 5.30, respectively. We have considered Calidi Biotherapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Calidi Biotherapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Calidi Biotherapeutics is based on 3 months time horizon.
Calidi Biotherapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Calidi Biotherapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Calidi Biotherapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Calidi Biotherapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.24 | 4.04 | 0.01 | 0.05 | 6 Events / Month | 6 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.24 | 1.23 | 0.81 |
|
Calidi Biotherapeutics Hype Timeline
Calidi Biotherapeutics is currently traded for 1.24. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.05. Calidi is forecasted to decline in value after the next headline, with the price expected to drop to 1.23. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.81%, whereas the daily expected return is currently at -0.24%. The volatility of related hype on Calidi Biotherapeutics is about 2082.47%, with the expected price after the next announcement by competition of 1.29. About 15.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Calidi Biotherapeutics had not issued any dividends in recent years. The entity had 1:12 split on the 5th of August 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Calidi Biotherapeutics Basic Forecasting Models to cross-verify your projections.Calidi Biotherapeutics Related Hype Analysis
Having access to credible news sources related to Calidi Biotherapeutics' direct competition is more important than ever and may enhance your ability to predict Calidi Biotherapeutics' future price movements. Getting to know how Calidi Biotherapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Calidi Biotherapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CMND | Clearmind Medicine Common | (0.07) | 11 per month | 0.00 | (0.42) | 8.47 | (21.84) | 56.34 | |
| CANF | Can Fite Biopharma | (0.17) | 9 per month | 0.00 | (0.26) | 8.16 | (8.11) | 38.79 | |
| KZIA | Kazia Therapeutics Ltd | 2.03 | 8 per month | 7.99 | 0.04 | 12.48 | (14.20) | 73.49 | |
| TTNP | Titan Pharmaceuticals | 0.19 | 2 per month | 5.38 | 0.03 | 9.38 | (8.08) | 30.41 | |
| SILO | Silo Pharma | 0.18 | 24 per month | 0.00 | (0.21) | 8.33 | (9.09) | 24.79 | |
| CNSP | CNS Pharmaceuticals | (0.03) | 8 per month | 0.00 | (0.12) | 5.99 | (6.36) | 18.23 | |
| SXTP | 60 Degrees Pharmaceuticals, | (0.01) | 9 per month | 0.00 | (0.19) | 6.90 | (7.45) | 35.46 | |
| XBIO | Xenetic Biosciences | 0.04 | 6 per month | 7.30 | 0.02 | 4.96 | (9.06) | 174.58 | |
| QLGN | Qualigen Therapeutics | (0.28) | 8 per month | 6.49 | 0.10 | 13.00 | (10.32) | 120.03 | |
| SNGX | Soligenix | 0.06 | 9 per month | 0.00 | (0.04) | 10.37 | (8.84) | 38.79 |
Calidi Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Calidi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Calidi using various technical indicators. When you analyze Calidi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Calidi Biotherapeutics Predictive Indicators
The successful prediction of Calidi Biotherapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Calidi Biotherapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Calidi Biotherapeutics based on analysis of Calidi Biotherapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Calidi Biotherapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Calidi Biotherapeutics's related companies. | 2010 | 2024 | 2025 (projected) | Dividend Yield | 0.18 | 0.16 | 0.14 | Price To Sales Ratio | 625.63 | 1.7K | 1.0K |
Story Coverage note for Calidi Biotherapeutics
The number of cover stories for Calidi Biotherapeutics depends on current market conditions and Calidi Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Calidi Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Calidi Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Calidi Biotherapeutics Short Properties
Calidi Biotherapeutics' future price predictability will typically decrease when Calidi Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Calidi Biotherapeutics often depends not only on the future outlook of the potential Calidi Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Calidi Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 664.4 K | |
| Cash And Short Term Investments | 9.6 M |
Complementary Tools for Calidi Stock analysis
When running Calidi Biotherapeutics' price analysis, check to measure Calidi Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calidi Biotherapeutics is operating at the current time. Most of Calidi Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Calidi Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calidi Biotherapeutics' price. Additionally, you may evaluate how the addition of Calidi Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |